These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 132511)

  • 1. Altered growth hormone release in Huntington's chorea.
    Keogh HJ; Johnson RH; Nanda RN; Sulaiman WR
    J Neurol Neurosurg Psychiatry; 1976 Mar; 39(3):244-8. PubMed ID: 132511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of hypothalamic function in Huntington's chorea.
    Lavin PJ; Bone I; Sheridan P
    J Neurol Neurosurg Psychiatry; 1981 May; 44(5):414-8. PubMed ID: 6455503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fatty acid patterns and glucose tolerance in Huntington's chorea (author's transl)].
    Schubotz R; Hausmann L; Kaffarnik H; Zehner J; Oepen H
    Res Exp Med (Berl); 1976 Jul; 167(3):203-15. PubMed ID: 136033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.
    Chalmers RJ; Johnson RH; Keogh HJ; Nanda RN
    J Neurol Neurosurg Psychiatry; 1978 Feb; 41(2):135-9. PubMed ID: 24678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma growth hormone concentrations in Huntington's chorea.
    Phillipson OT; Bird ED
    Clin Sci Mol Med; 1976 Jun; 50(6):551-4. PubMed ID: 132332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exaggerated growth hormone response to arginine infusion in Huntington's disease.
    Leopold NA; Podolsky S
    J Clin Endocrinol Metab; 1975 Jul; 41(1):160-3. PubMed ID: 125287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal glucose tolerance and arginine tolerance tests in Huntington's disease.
    Podolsky S; Leopold NA
    Gerontology; 1977; 23(1):55-63. PubMed ID: 136379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EEG in Huntington's chorea: a clinical and neuropathological study.
    Scott DF; Heathfield KW; Toone B; Margerison JH
    J Neurol Neurosurg Psychiatry; 1972 Feb; 35(1):97-102. PubMed ID: 4260288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration.
    Podolsky S; Leopold NA
    J Clin Endocrinol Metab; 1974 Jul; 39(1):36-9. PubMed ID: 4276011
    [No Abstract]   [Full Text] [Related]  

  • 10. Impaired prolactin release in Huntington's chorea. Evidence for dopaminergic excess.
    Hayden MR; Vinik AI; Paul M; Beighton P
    Lancet; 1977 Aug; 2(8035):423-6. PubMed ID: 70642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.
    Kalliolia E; Silajdžić E; Nambron R; Costelloe SJ; Martin NG; Hill NR; Frost C; Watt HC; Hindmarsh P; Björkqvist M; Warner TT
    PLoS One; 2015; 10(10):e0138848. PubMed ID: 26431314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs.
    Ader M; Agajanian T; Finegood DT; Bergman RN
    Endocrinology; 1987 Feb; 120(2):725-31. PubMed ID: 3542508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study.
    Gonzalez V; Cif L; Biolsi B; Garcia-Ptacek S; Seychelles A; Sanrey E; Descours I; Coubes C; de Moura AM; Corlobe A; James S; Roujeau T; Coubes P
    J Neurosurg; 2014 Jul; 121(1):114-22. PubMed ID: 24702329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Huntington's chorea and somatotropic hormone: dynamic explorations in 27 cases (author's transl)].
    Destée A; Petit H; Fossati P; Warot P
    Rev Neurol (Paris); 1981; 137(1):21-31. PubMed ID: 6453416
    [No Abstract]   [Full Text] [Related]  

  • 15. A Metabolic Study of Huntington's Disease.
    Nambron R; Silajdžić E; Kalliolia E; Ottolenghi C; Hindmarsh P; Hill NR; Costelloe SJ; Martin NG; Positano V; Watt HC; Frost C; Björkqvist M; Warner TT
    PLoS One; 2016; 11(1):e0146480. PubMed ID: 26744893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone secretion in protein energy malnutrition.
    Günöz H; Neyzł O; Sencer E; Molvalilar S; Argun A
    Acta Paediatr Scand; 1981 Jul; 70(4):521-6. PubMed ID: 6797233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease.
    Durso R; Tamminga CA; Ruggeri S; Denaro A; Kuo S; Chase TN
    J Neurol Neurosurg Psychiatry; 1983 Dec; 46(12):1134-7. PubMed ID: 6229607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the amino-terminal portion of human growth hormone on glucose clearance and metabolism in normal, diabetic, hypophysectomized, and diabetic-hypophysectomized rats.
    Salem MA
    Endocrinology; 1988 Sep; 123(3):1565-76. PubMed ID: 3042372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the regularity of involuntary muscle contractions in vascular chorea with that in Huntington's chorea, hemiballism and parkinsonian tremor.
    Hashimoto T; Yanagisawa N
    J Neurol Sci; 1994 Aug; 125(1):87-94. PubMed ID: 7964894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site.
    Rosenfeld RG; Wilson DM; Dollar LA; Bennett A; Hintz RL
    J Clin Endocrinol Metab; 1982 May; 54(5):1033-8. PubMed ID: 7037819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.